Alberico L. Catapano - Publications, H-index & Citations

Alberico L. Catapano

irccs multimedica

123H指数

1.3K论文数

13.5W被引数

收录论文 515

发表时间

Lipids and abdominal aortic aneurysm: from pathophysiology to therapy. A call to action from SISA and SIAPAV 脂质与腹主动脉瘤：从病理生理学到治疗。SISA和SIAPAV的呼吁行动

nutrition, metabolism and cardiovascular diseases

IF0

2026-07-01

PREAI

Rossella Marcucci; Marco Bucci; Walter Ageno; Marcello Arca; Maurizio Averna; Carlo M. Barbagallo; Alberto Corsini; Giuliana Fortunato; Francesca Ghirardini; Matteo Pirro; Patrizia Suppressa; Paolo Zamboni; Maria Grazia Zenti; Romeo Martini; Alberico L. Catapano; Laura D'Erasmo; Luigi Gentile

Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry 纯合子家族性高胆固醇血症：全球HICC登记研究的见解

European Heart Journal

IF35.6

2026-05-18

PREAI

Willemijn A M Schonck; Janneke W C M Mulder; Marina Cuchel; Laurens F Reeskamp; Fahad Alnouri; Iulia Iatan; Tomas Freiberger; Meral Kayıkçıoğlu; Tycho R Tromp; M Doortje Reijman; Albert Wiegman; G Kees Hovingh; Jeanine E Roeters van Lennep; Frederick J Raal; Dirk J Blom; Alberico L Catapano

Homozygous familial hypercholesterolemia: Will new LDL-C-lowering drugs replace lipoprotein apheresis?纯合子家族性高胆固醇血症：新型LDL-C降低药物能否取代脂蛋白去除术？

European Journal of Preventive Cardiology

IF7.5

2026-05-09

PREAI

Angela Pirillo; Alberico L Catapano

ARE WE UNDERESTIMATING THE BENEFITS OF LIPID-LOWERING THERAPIES?我们是否低估了降脂疗法的益处？

Pharmacological Reviews

IF17.3

2026-05-08

PREAI

Angela Pirillo; Manuela Casula; Elena Olmastroni; Stefano Scotti; Alberto Corsini; Alberico L. Catapano

Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial 作者更正：奥昔特瑞匹在杂合子家族性高胆固醇血症患者中的应用：布鲁克林随机临床试验

Nature Medicine

IF50

2026-04-17

PREAI

Stephen J. Nicholls; Adam J. Nelson; Marc Ditmarsch; John J. P. Kastelein; Christie M. Ballantyne; Kausik K. Ray; Ann Marie Navar; Steven E. Nissen; Anne C. Goldberg; Liam R. Brunham; Erin Wuerdeman; Annie L. Neild; Douglas Kling; Andrew Hsieh; Julie Butters; Brian A. Ference; Ulrich Laufs; Maciej Banach; Roxana Mehran; Alberico L. Catapano; Michael Szarek; Violeta Balinskaite; Michael H. Davidson

CX3CR1-T280M polymorphism and end-stage renal disease development in chronic kidney disease CX3CR1-T280M多态性与慢性肾脏病进展至终末期肾病的关系

Scientific Reports

IF3.9

2026-04-03

OAAI

Matteo Gatti; Ivano Baragetti; Andrea Baragetti; Laura Buzzi; Andrea Lupi; Angelo Fassio; Elena Olmastroni; Alberico L. Catapano; Paolo Fabbrini

Oral PCSK9 Inhibitor Enlicitide versus Oral Non-statin Therapies: A Phase 3 Randomized Clinical Trial 口服PCSK9抑制剂Enlicitide与口服非他汀类疗法：一项III期随机临床试验

JACC

IF0

2026-03-30

PREAI

Alberico L. Catapano; Elina Mikhailova; Ann Marie Navar; Puja Banka; Pablo Corral; Manish Saxena; P.Gabriel Steg; Subodh Verma; Andrew Yacoub Kordahi; Geraldine Mendizabal; Pengfei Zhu; Christie M. Ballantyne

Upfront Combination or Stepwise Escalation: Personalising LDL-C Reduction in Clinical Practice upfront combination or stepwise escalation: 个性化临床实践中LDL-C降低方案

Current Atherosclerosis Reports

IF5.2

2026-02-27

PREAI

Angela Pirillo; Alberico L. Catapano

Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial Obicetrapib治疗杂合子家族性高胆固醇血症: 布鲁克林随机临床试验

Nature Medicine

IF50

2026-02-27

PREAI

Lipid-lowering therapy and LDL cholesterol control among high- and very high-risk patients in Portugal: An analysis of the SANTORINI study 葡萄牙高危及极高危患者中的降脂疗法和LDL胆固醇控制：SANTORINI研究分析

Revista Portuguesa de Cardiologia

IF1.6

2026-02-01

OAAI

Aguiar, Carlos; Aguiar, Patricio; Duarte, Joao Sequeira; Gil, Victor; Mimoso, Jorge; Monteiro, Pedro; Pinto, Fausto J.; Pinto, Fernando; Raposo, Joao; Von Hafe, Pedro; Ruivo, Jorge A.; Teixeira, Carla; Catapano, Alberico L.; Ray, Kausik K.

Fibrates : Do They Still Have a Role in Therapy in 2025?贝特类药物：它们在2025年的治疗中是否仍有作用？

Current Atherosclerosis Reports

IF5.2

2025-12-26

PREAI

Angela Pirillo; Alberto Zambon; Alberico L. Catapano

Cardiovascular Prevention in Children, Adolescents, and Young Adults. A Call-to-Action of the Italian Societies of Pediatrics (SIP), Hypertension (SIIA), Study of Atherosclerosis (SISA), and Cardiovascular Prevention (SIPREC)儿童、青少年和年轻成人心血管预防。意大利儿科学会（SIP）、高血压学会（SIIA）、动脉粥样硬化研究学会（SISA）和心血管预防学会（SIPREC）的呼吁行动。

High Blood Pressure & Cardiovascular Prevention

IF2.9

2025-12-09

OAAI

Simonetta Genovesi; Roberto Volpe; Davide Agnoletti; Simonetta Bellone; Gianni Bona; Manuela Casula; Luigi Gentile; Francesca Saladini; Rino Agostiniani; Agostino Virdis; Alberico L. Catapano; Massimo Volpe; Marco Giussani

Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience 观察性、多中心研究关于aliROcumab的长期有效性和耐受性（OMERO）：一项意大利真实世界经验

International Journal of Cardiology Cardiovascular Risk and Prevention

IF2.1

2025-12-01

OAAI

Catapano, Alberico L.; Maggioni, Aldo Pietro; Rossi, Francesco; Consolo, Eleonora; Notarianni, Lucia; Agnelli, Giancarlo

PORTRAIT Survey: Patient-Centered Overview Related to Treatment Practices in Lipoprotein Apheresis: Italian Investigating Trajectories PORTRAIT调查：与脂蛋白去除治疗实践相关的人本护理概述：意大利调查轨迹

THERAPEUTIC APHERESIS AND DIALYSIS

IF1.2

2025-11-01

PREAI

Sbrana, Francesco; Dal Pino, Beatrice; Corciulo, Carmen; Bigazzi, Federico; Casula, Manuela; Catapano, Alberico L.; Medde, Paolo; Sampietro, Tiziana; Zenti, Maria Grazia

Not all fibrates are made equal: Learning from biology and clinical trials 并非所有贝特类药物都完全相同：从生物学和临床试验中学习

Atherosclerosis

IF5.7

2025-10-29

PREAI

Alberto Zambon; Bart Staels; Michel Farnier; Michal Vrablik; Alberico L. Catapano

Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort 实现LDL-C目标面临的挑战：意大利SANTORINI研究队列的见解

Nutrition, Metabolism and Cardiovascular Diseases

IF0

2025-10-14

PREAI

Marcello Arca; Paolo Calabrò; Anna Solini; Angela Pirillo; Rosanna Gambacurta; Kausik K. Ray; Alberico L. Catapano

The two faces of cholesteryl ester transfer protein inhibitors 胆固醇酯转移蛋白抑制剂的两种面相

Current Opinion in Lipidology

IF4.6

2025-10-13

PREAI

Pirillo, Angelaa; Catapano, Alberico L.b, c

Lipid-lowering therapy treatment regimens in high- and very high-risk patients for the prevention of cardiovascular events: results from the Irish cohort of the multinational, observational SANTORINI study 高危和极高危患者预防心血管事件的降脂治疗方案: 来自多国观察性圣托里尼研究爱尔兰队列的结果

IRISH JOURNAL OF MEDICAL SCIENCE

IF1.6

2025-10-01

PREAI

Rai, Himanshu; Coughlan, John Joseph; O'callaghan, Daniel; Sheahan, Richard; Murphy, Ross; Burke, David; Mcfadden, Eugene; Nolan, Dermot; Colleran, Roisin; Hazeez-Agbaje, Abiola; Ray, Kausik K.; Catapano, Alberico L.; Byrne, Robert A.

Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study 动脉粥样硬化性心血管事件后启动降脂治疗的预测因素与获益：一项回顾性队列研究

Frontiers in Pharmacology

IF4.8

2025-09-26

OAAI

Manuela Casula; Stefano Scotti; Federica Galimberti; Giacomo Matteo Bruno†; Giorgio Lorenzo Colombo†; Asiiat Alieva; Sining Xie†; Alberico Luigi Catapano; Elena Olmastroni

Triglycerides as Determinants of Global Lipoprotein Derangement: Implications for Cardiovascular Prevention 甘油三酯作为全球脂蛋白紊乱的决定因素：对心血管预防的启示

International Journal of Molecular Sciences 2025, Vol. 26, Page 8284

IF4.9

2025-09-03

OAAI

Núria Amigó; Pol Torné; Liv T. Nordestgaard; Francesco Di Giacomo-Barbagallo; Carla Merino; Paolo Magni; Ana González-Lleó; Natalia Andreychuk; Alberico L. Catapano; Lluís Masana; Daiana Ibarretxe

研究方向